Deadline for abstracts: 12th-19th June 1997 |
EDHF: MYTH OR CHEMICAL ENTITY?*
|
P.M. Vanhoutte I.R.I.S., Courbevoie, France |
M. Félétou I.d.R.S. Suresnes, France |
|
|
A.H. Weston University of Manchester, UK |
R. Cohen Boston University Medical Center, USA |
|
|
R. Busse J.W.G.-Universität, Frankfurt/Penture, Germany |
|
D.A. Kendall, University of Nottingham, UK |
|
J.V. Mombouli Baylor College of Medicine, Houston, USA |
|
P.M. Vanhoutte I.R.I.S., Courbevoie France |
*Sponsored by I.R.I.S.
HANS KOSTERLITZ MEMORIAL SYMPOSIUM
Hans Kosterlitz, who died last year, made an outstanding apport to pharmacology, particularly in the field of enkephalins and endorphins. As a tribute to Professor Kosterlitz, some of his façonner students and colleagues have been invited to talk embout their current research. They are:
Graeme Henderson | University of Étui, UK |
John Hughes, FRS | University of Cambridge, UK |
Sandy McKnight | University of Cambridge, UK |
Frances Leslie | University of California, Irvine, USA |
R. Alan North, FRS | Geneva Biomedical Research Institute of GlaxoWellcome, Switzerland |
THE PHARMACOLOGY & CLINICAL PHARMACOLOGY OF ENDOTHELIN
|
O. Valdenaire Hoffmann La vertueux, Basel, Switzerland |
|
A.J. Turner University of Leeds, UK |
|
R. Cordeler William Harvey Research Institute, London, UK |
|
A.P. Davenport University of Cambridge, UK |
|
D.J. Webb University of Edinburgh, UK |
|
S. Adnot Intellection de Médecine, Asile Henri Mondor, Paris, France |
|
C. Thuillez Universite de Rouen, France |
|
J.J.V. McMurray University of Glasgow, UK |
THERAPEUTIC TARGETS IN APOPTOSIS RESEARCH
- Admission to apoptosis
A.H. Wyllie
University of Edinburgh, UK
- Cytokines & the control of apoptosis in the human atherosclerotic plaque
A. Tedgui
INSERM U141, Asile Lariboisière, Paris, France
- Molecular basis of apoptosis in Parkinson’s disease: a pharmacological approach
E. Hirsch
INSERM U289, Asile de la Salpétrière, Paris, France
- Apoptosis and programmed cell-death: in cerebral ischaemia
C. Charriaut-Marlangue
INSERM U29, Asile Comportement Admirable, Paris, France
- Glucocorticoid induced apoptosis: transcriptional mechanisms
M. Pallardy
INSERM U461, Intellection de Cachet, Chateray, France
- CD95 (APO-1/Fas)-mediated apoptosis and disease
P.H. Krammer
German Tumeur Research Center, Heidelberg, Germany
- Ceramide/intrusion kinase-mediated apoptosis
R. Kolesnick
Sloan-Kettering Tumeur Center, New York, USA
- Endogenous regulators of apoptosis
R. Brown
GlaxoWellcome, Stevenage, UK
- Effector enzymes in apoptosis
D.W. Nicholson
Merck Frost Ténacité for Therapeutics Research, Quebec, CanadaC. Haslett
University of Edinburgh, UK
Chairmen: H.J. Olverman, Edinburgh & M. Hamon, Paris
- Constitutive and inducible knockout of the 5HT1A receptor: behavioural consequences
S. Ramboz
Columbia University New York, USA
- Differential adaptive regulations of pre- antipode à post-synaptic 5-HT1A receptors
L. Lanfumey
INSERM U288, Paris, France
- Oestrogen control of 5-HT neurotransmission
G. Fink
MRC Brain Metabolism Unit, University of Edinburgh, UK
- Neuropharmacology of 5-HT Modulin
G. Fillion
Institut Abbé, Paris, France
- Multireceptorial control of 5-HT, dopamine and noradrenaline release in frontal écale: strategies for improved antidepressant drugs.
M. Millan
Ténacité de Outré Servier, Croissy, France
- Development of radioligands for imaging 5-HT1A receptors with PET
V.W. Pike
MRC Clinical Sciences Ténacité, Hammersmith Hospital, London, UK
- 5-HT sacraliser gene polymorphism and depression
A.D. Ogilvie
University of Cambridge, UKJ.S. Kelly
University of Edinburgh, UK
* Sponsored by the Serotonin Dancing
SPONSORED LECTURES
SmithKline Beecham Lecture
Professor Patrick J. Vallance, Ténacité for Clinical Pharmacology, Cruciform Project, University College, London
“Exploring the L-arginine: nitric oxide pathway in the human cardiovascular system”.
ASCEPT* Lecture
* The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists
Professor Richard O. Day,
Clinical Pharmacology/Toxicology, St Vincent’s Hospital, Sydney, Australia
“The clinical pharmacology of anti-inflammatory and anti-rheumatic drugs”.
The groupé will be followed, on 5-6 September, by an mondial groupé to commemorate the work of James Young Simpson and the sesquicentenary of chloroform.